Literature DB >> 22612806

Are you in or out? Leukocyte, ion, and neurotransmitter permeability across the epileptic blood-brain barrier.

Damir Janigro1.   

Abstract

The credo that epileptic seizures can be initiated only by "epileptic" neurons has been recently challenged. The recognition of key astrocytic-neuronal communication, and the close interaction and crosstalk between astrocytes and brain endothelial cells, has shifted attention to the blood-brain barrier (BBB) and the "neurovascular unit." Therefore, the pursuit of mechanisms of seizure generation and epileptogenesis now includes investigations of cerebral blood flow and permeability of cerebral microvessels. For example, leukocyte adhesion molecules at the BBB have been proposed to play a role as an initiating factor for pilocarpine-induced status epilepticus, and a viral infection model with a strong BBB etiology has been used to study epileptogenesis. Finally, the fact that in nonepileptic subjects seizures can be triggered by BBB disruption, together with the antiseizure effects obtained by administration of potent antiinflammatory "BBB repair" drugs, has increased the interest in neuroinflammation; both circulating leukocytes and resident microglia have been studied in this context. The dual scope of this review is the following: (1) outline the proposed role of BBB damage and immune cell activation in seizure disorders; and (2) explain how increased cerebrovascular permeability causes neuronal misfiring. The temporal sequence linking seizures to peripheral inflammation and BBB dysfunction remains to be clarified. For example, it is still debated whether seizures cause systemic inflammation or vice versa. The topographic localization of fundamental triggers of epileptic seizures also remains controversial: Are immunologic mechanisms required for seizure generation brain-specific or is systemic activation of immunity sufficient to alter neuronal excitability? Finally, the causative role of "BBB leakage" remains a largely unresolved issue. Wiley Periodicals, Inc.
© 2012 International League Against Epilepsy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22612806      PMCID: PMC4093790          DOI: 10.1111/j.1528-1167.2012.03472.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  77 in total

Review 1.  Perforin: structure, function, and role in human immunopathology.

Authors:  Ilia Voskoboinik; Michelle A Dunstone; Katherine Baran; James C Whisstock; Joseph A Trapani
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

Review 2.  Transporters in drug-refractory epilepsy: clinical significance.

Authors:  N Marchi; J Gonzalez-Martinez; M-T Nguyen; T Granata; D Janigro
Journal:  Clin Pharmacol Ther       Date:  2010-01       Impact factor: 6.875

3.  Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures.

Authors:  Mattia Maroso; Silvia Balosso; Teresa Ravizza; Jaron Liu; Eleonora Aronica; Anand M Iyer; Carlo Rossetti; Monica Molteni; Maura Casalgrandi; Angelo A Manfredi; Marco E Bianchi; Annamaria Vezzani
Journal:  Nat Med       Date:  2010-03-28       Impact factor: 53.440

4.  Blood-brain barrier damage, but not parenchymal white blood cells, is a hallmark of seizure activity.

Authors:  Nicola Marchi; Qingshan Teng; Chaitali Ghosh; Qingyuan Fan; Minh T Nguyen; Nirav K Desai; Harpreet Bawa; Peter Rasmussen; Thomas K Masaryk; Damir Janigro
Journal:  Brain Res       Date:  2010-06-27       Impact factor: 3.252

5.  Blood-brain barrier breakdown as a novel mechanism underlying cerebral hyperperfusion syndrome.

Authors:  Sebastian Ivens; Szendro Gabriel; George Greenberg; Alon Friedman; Ilan Shelef
Journal:  J Neurol       Date:  2009-11-22       Impact factor: 4.849

Review 6.  The emerging role for chemokines in epilepsy.

Authors:  Paolo F Fabene; Placido Bramanti; Gabriela Constantin
Journal:  J Neuroimmunol       Date:  2010-06-09       Impact factor: 3.478

7.  Chronic dysfunction of astrocytic inwardly rectifying K+ channels specific to the neocortical epileptic focus after fluid percussion injury in the rat.

Authors:  Tessandra H Stewart; Clifford L Eastman; Peter A Groblewski; Jason S Fender; Derek R Verley; David G Cook; Raimondo D'Ambrosio
Journal:  J Neurophysiol       Date:  2010-09-22       Impact factor: 2.714

8.  Multimodal investigations of trans-endothelial cell trafficking under condition of disrupted blood-brain barrier integrity.

Authors:  Nicola Marchi; Qingshan Teng; Minh T Nguyen; Linda Franic; Nirav K Desai; Thomas Masaryk; Peter Rasmussen; Silvia Trasciatti; Damir Janigro
Journal:  BMC Neurosci       Date:  2010-03-09       Impact factor: 3.288

9.  Treatment of refractory epilepsy with natalizumab in a patient with multiple sclerosis. Case report.

Authors:  Stefano Sotgiu; Maria R Murrighile; Gabriela Constantin
Journal:  BMC Neurol       Date:  2010-09-23       Impact factor: 2.474

10.  Pattern of P450 expression at the human blood-brain barrier: roles of epileptic condition and laminar flow.

Authors:  Chaitali Ghosh; Jorge Gonzalez-Martinez; Mohammed Hossain; Luca Cucullo; Vincent Fazio; Damir Janigro; Nicola Marchi
Journal:  Epilepsia       Date:  2010-01-13       Impact factor: 5.864

View more
  42 in total

Review 1.  Defining the therapeutic time window for suppressing the inflammatory prostaglandin E2 signaling after status epilepticus.

Authors:  Yifeng Du; Timothy Kemper; Jiange Qiu; Jianxiong Jiang
Journal:  Expert Rev Neurother       Date:  2016-01-13       Impact factor: 4.618

Review 2.  Inflammatory pathways of seizure disorders.

Authors:  Nicola Marchi; Tiziana Granata; Damir Janigro
Journal:  Trends Neurosci       Date:  2013-12-16       Impact factor: 13.837

3.  Intracellular and circulating neuronal antinuclear antibodies in human epilepsy.

Authors:  Philip H Iffland; Juliana Carvalho-Tavares; Abhishek Trigunaite; Shumei Man; Peter Rasmussen; Andreas Alexopoulos; Chaitali Ghosh; Trine N Jørgensen; Damir Janigro
Journal:  Neurobiol Dis       Date:  2013-07-21       Impact factor: 5.996

4.  Losartan prevents acquired epilepsy via TGF-β signaling suppression.

Authors:  Guy Bar-Klein; Luisa P Cacheaux; Lyn Kamintsky; Ofer Prager; Itai Weissberg; Karl Schoknecht; Paul Cheng; Soo Young Kim; Lydia Wood; Uwe Heinemann; Daniela Kaufer; Alon Friedman
Journal:  Ann Neurol       Date:  2014-05-28       Impact factor: 10.422

Review 5.  Obstructive sleep apnea and cognitive impairment: addressing the blood-brain barrier.

Authors:  Diane C Lim; Allan I Pack
Journal:  Sleep Med Rev       Date:  2013-03-28       Impact factor: 11.609

6.  Independent impact of infections on the course and outcome of status epilepticus: a 10-year cohort study.

Authors:  Saskia Semmlack; Sarah Tschudin-Sutter; Andreas F Widmer; Martina Valença; Stephan Rüegg; Stephan Marsch; Raoul Sutter
Journal:  J Neurol       Date:  2016-05-03       Impact factor: 4.849

Review 7.  Breakdown of blood brain barrier as a mechanism of post-traumatic epilepsy.

Authors:  Aaron Dadas; Damir Janigro
Journal:  Neurobiol Dis       Date:  2018-07-18       Impact factor: 5.996

8.  Does Systemic Inflammation Play a Role in Pediatric Psychosis?

Authors:  Tatiana Falcone; Erin Carlton; Catherine Lee; Mattia Janigro; Vince Fazio; Fernando Espi Forcen; Kathleen Franco; Damir Janigro
Journal:  Clin Schizophr Relat Psychoses       Date:  2013-03-14

Review 9.  Cerebrovascular remodeling and epilepsy.

Authors:  Nicola Marchi; Mireille Lerner-Natoli
Journal:  Neuroscientist       Date:  2012-10-16       Impact factor: 7.519

Review 10.  New immunological approaches in treating and diagnosing CNS diseases.

Authors:  Kathy Guo; Damir Janigro
Journal:  Pharm Pat Anal       Date:  2013-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.